Alexander Lin, MD

Radiation Oncology
Accepting new patients
Sees patients age 18 and up
Penn Radiation Oncology Perelman-Concourse Level
Headshot of Alexander Lin, MD
Penn Medicine Provider

About me

  • Vice Chair, Faculty Affairs, Radiation Oncology
  • Morton M. Kligerman M.D. Professor

My education and training

  • Medical School: University of Michigan
  • Residency: University of Michigan Health

Spoken languages

English
English

Reviews

Average Rating

288 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
June 2026
dr lin cares, he is one of the greatest doctors i was so blessed to have had him set my treatment plan!
Anonymous
June 2026
attentive
Anonymous
June 2026
all good
Anonymous
May 2026
leader in his field

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Chester County Hospital: Has privileges to treat patients in the hospital.
Dr. Lin is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Chang A, Jacoby D, Lin A, Lukens JN, Deng J, Banas S, Zheng J Lymphedema therapy in head & neck cancer with carotid stenosis: a systematic review and care pathway , Oral Oncology: 2026 (online ahead of print)


Lukens JN*, Riina MD*, Weinstein G, MacDuffie E, Ramkissoon A, Baron J, Berger M, Messing I, Gentile M, Maxwell R, Ojerholm E, Swisher-McClure S, Santos AG, Porier K, Basu D, Brody R, Cannady S, Carey R, Chalian A, Newman J, Rajasekaran K, Rassekh C, Shanti R, Cohen RB, Singh A, Sun L, Montone K, Lin A Long-Term Results of a Phase II Clinical Trial of Radiation Volume and Dose De-intensification Following Transoral Robotic Surgery and Neck Dissection for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma , International Journal of Radiation Oncology, Biology, Physics: 2026 (accepted)


Wright JL, Ko K, Kenworthy W, Bosch W, Straube W, Zou W, Remmes N, Pankuch M, Berlin E, Berrington de Gonzalez A, Boggs DH, Braunstein LZ, Cahlon O, Chawla A, Croog V, Fagundes M, Fang LC, Feriozzi A, Freedman GM, Gillespie E, Hoffman K, Jimenez RB, Kim J, Lu HL, MacDonald S, Meier T, Mishra M, Mutter R, Ohri N, Pugh SL, Rosen L, Taghian A, Taunk N, Thukral AD, Urbanic J, Bekelman JE, Lin A, Ky B; RadComp Consortium Associations Between Cardiac Radiation Dose-Volume Metrics and Health-Related Quality of Life for Patients With Breast Cancer on the RadComp Trial , International Journal of Radiation Oncology, Biology, Physics: 2026 (accepted)


Halle TR, Cao AC, Naik AG, Weinstein GS, Lee JJ, Gobillot TA, Kaye ER, Brody RM, Basu D, O’Malley Jr BW, Farwell DG, Cannady SB, Lin A, Lukens J, Gentile M, Newman JG, Chalian AA, Rassekh CH, Rajasekaran K Risk of occult contralateral neck metastasis in early-stage HPV-related lateralized cancer of the base of the tongue , Head and Neck, 48(4): 2026,986-993


Setianegara J, Verginadis II, Koumenis C, Teo BK, Lin A FLASH Particle Radiotherapy , The Cancer Journal, 32(2): 2026,e0816


Gallant J, Rich DJ, Raghav L, Sannigrahi MK, Patria JN, Mishra SK, Lin A, Brody RM, Gimotty PA, Jalaly JB, Mirabello L, Devraj Basu D Molecular etiology and clinical significance of discordant HPV testing in p16+ oropharyngeal cancers , JCO Precision Oncology: 2026,e2501030


Frank SJ, Busse PM, Lee JJ, Rosenthal DI, Hernandez M, Swanson DM, Garden AS, Gunn GB, Patel SH, Snider JW, Ma DJ, Molitoris JK, Lee NY, Parvathaneni U, McDonald MW, Kalman NS, Lin A, Mohammed N, Henson C, Hyde C, Bajaj GK, Katz SR, Dagan R, Morrison WH, Reddy JP, Fuller CD, Shah SJ, Phan J, Chronowski GM, Mayo L, Sturgis EM, Ferrarotto R, Zhu XR, Zhang X, Wang L, Hutcheson KA, El-Naggar AK, Moreno AC, Lee A, Spiotto MT, Gross ND, Lai SY, Liao JJ, Jonathan Paly J, Liao Z, and Foote RL on behalf of The University of Texas MD Anderson Cancer Center Clinical Trial Consortium Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: a multicentre, randomised, open-label, non-inferiority phase 3 trial , Lancet, 407(10524): 2026,174-184


Deng J, Lukens JN, Murphy BA, McMenamin E, Rajasekaran K, Quinn RJ, Cohn JC, Schlessinger W, Andersen LP, Spinelli BA, Lin A Photobiomodulation in Treatment of Head and Neck Cancer-Related Chronic Lymphedema: A Pilot Randomized Controlled Trial , Integrative Cancer Therapies, 25: 2026,15347354261439138


Gobillot TA, Weinstein G, Cao A, Lee JJ, Brody RM, Basu D, O’Malley Jr BW, Cannady S, Lin A, Lukens J, Gentile M, Newman J, Chalian AA, Sun S, Cohen R, Rasskeh CH, Rajasekaran K Outcomes of HPV+ oropharyngeal carcinoma of unknown primary following transoral robotic surgery , The Laryngoscope, 135(12): 2025,4707-4715


Rose AM, Helgeson ES, Kimberly C. Valentino KC, Lalla RV, Treister NS, Schmidt BL, Patton LL, Lin A, Brennan MT, Sollecito TP The Impact of Medications on Salivary Flow and Oral Health-Related Quality of Life in Post-Radiation Head and Neck Cancer Patients: Results of the OraRad Study , Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 140(5): 2025,577-586